Phase I clinical evaluation of carboplatin in tumor-bearing cats: A veterinary cooperative oncology group study

Journal of Veterinary Internal Medicine

Volumn 22, Issue 1, 2008, Pages 83-88

  Kisseberth, W C ^a,b   Vail, D M ^a   Yaissle, J ^b   Jeglum, K A ^c   Couto, C G ^b   Ward, H ^b,f   Khanna, C ^d,g   Obradovich, J E ^e,h  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Vet Oncol Serv and Res Center   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e Oakland Veterinary Referral Services   (United States)

^f Gulf Coast Veterinary Oncology ^*  (United States)

^g Animal Cancer Investigation LLC   (United States)

^h Animal Cancer & Imaging Center Michigan   (United States)

Author keywords

Chemotherapy; Feline; Injection site associated sarcoma; Maximally tolerated dose; Toxicity.

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CREATININE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; CAT DISEASE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; KIDNEY DISEASE; MALE; MULTICENTER STUDY; NEOPLASM; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; THROMBOCYTOPENIA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CAT DISEASES; CATS; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; KIDNEY DISEASES; MALE; NEOPLASMS; NEUTROPENIA; THROMBOCYTOPENIA;

FELIDAE;

EID: 40549115331     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2007.0017.x     Document Type: Article

References (14)